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Free antiretroviral treatment is not 
without cost to the patient
Rosen et al. (p. 524) conducted a longitudinal study among 
recipients of free antiretroviral treatment (ART) at clinics and 
other facilities in Gauteng and Mpumalanga to estimate the 
cost that patients incur in obtaining this treatment. Patients 
must visit the health facility at least 9 times a year for 
treatment, and the researchers found the average out-of-pocket 
cost per visit to be R96 (about US$13) across the entire sample, 
plus travel and waiting time.
Much of the cost was attributable to transport, clinic fees, 
payment of substitute labour, income loss, purchase of special 
foods and medicines, and caretaker time. There was striking 
variation within the sample, however, with 5% reporting no 
cost, and a relatively small proportion of respondents incurring 
disproportionately high expenditure. Nevertheless, the authors 
speculate (something not specifically explored in the study) that 
‘the cost incurred even by the 25% of subjects who spent the 
least makes it likely that cost is deterring many eligible patients 
from enrolling or remaining in treatment programmes’.
Diagnosis of TB in HIV – ‘educated 
guess’ when smear is negative
Pulmonary tuberculosis (PTB) is the commonest cause of 
morbidity in HIV-infected individuals. Indeed at autopsy, half 
the patients dying from HIV are found also to be infected with 
TB, and half of these were not diagnosed ante mortem. As a rule, 
the disease tends to be rapidly progressive, leading to early 
death. Yet the sputum in such patients is twice as likely to be 
smear-negative, resulting in management dilemmas. Sputum 
culture, a more sensitive test, takes at least 8 weeks to yield 
results. For this reason, clinico-radiological algorithms have 
been devised to permit an early presumptive diagnosis and 
initiation of therapy pending the outcome of sputum cultures.
Saranchuk and colleagues (p. 517) conducted a prospective 
study to validate one such algorithm in Khayelitsha, Cape 
Town. Essentially, patients with deteriorating function who 
were unresponsive to antibiotics, and whose radiographs were 
consistent with PTB, were provisionally presumed to have 
active PTB infection, and put on treatment. Meanwhile, cultures 
of sputum, pleural effusion or lymph node aspirate were 
obtained.
Culture results confirmed the diagnosis of TB in 55.2% of the 
cases. However, a further 36% whose cultures were negative 
were nonetheless regarded by the authors as ‘probable’ or 
‘possible’ active TB cases and continued on treatment. All in all, 
‘91% of patients commenced on empirical TB treatment based 
on clinico-radiological diagnosis showed a (positive) response 
to therapy’ irrespective of the subsequent culture results. The 
take-home lesson from this study would therefore seem to be: 
in a public clinic situated in a setting similar to Khayelitsha, 
if an HIV-positive patient looks like they have PTB, and the 
radiological picture is compatible with tuberculosis, they are 
more than likely to improve on empirical treatment, and the 
patient will benefit from the prompt initiation and continuation 
of standard TB treatment irrespective of the results of the 




Marino et al. (p. 534) investigated the potential for microbial 
contamination during the in-hospital preparation of powdered 
infant feed (PIF), and found that there was significant 
contamination even when preparation occurred in a 
controlled environment, in essence confirming what has been 
demonstrated in ‘a significant body of international data’.
The current study found that 30% of PIFs studied, including 
those that were newly prepared, were heavily contaminated 
with bacteria. Opportunities for contamination arise during 
mixing and addition of additives, and when prepared food 
is allowed to stand in the milk kitchen or the ward. There 
are specific recommendations for handling PIFs, including 
appropriate water temperature at reconstitution, cooling, 
transportation to the ward in a refrigerated trolley, and storage 
in an industrial fridge at 4oC. In most settings these are either 
not feasible or not followed even in the best-equipped hospitals. 
The authors recommend the replacement of PIFs with pre-
packaged ready-to-use infant feeds, which the authors consider 
to be sterile and safer.
Non-steroidal anti-inflammatories? 
Think embolic event!
The widely used non-steroidal anti-inflammatory drugs 
(NSAIDs), many available without prescription, are not 
without potentially serious risk. In a comprehensive review 
of this class of drugs, Chin and Commerford (p. 500) caution 
that ‘there is now strong evidence to suggest that both the 
traditional NSAIDs (excluding aspirin) and the COX-2 
inhibitors are associated with an increased risk of thrombotic 
events (including myocardial infarction and stroke) and excess 
mortality both in patients with and without pre-existing 
cardiovascular disease’.
Following an exhaustive review of systematic reviews and 
meta-analyses, the authors conclude that COX-2 inhibitors 
are contraindicated in patients with ischaemic heart disease 
or stroke. Caution is advised in respect of patients with 
hypertension, diabetes or hypercholesterolaemia. Because 
NSAIDs are used for symptom relief rather than disease 
modification, the authors caution against ‘reflex prescription’ of 
these agents, and plead for measured and judicious use. 
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